DARUSENTAN
UNII 33JD57L6RW

Substance Identification & Data

This profile provides standardized clinical and technical data for Darusentan, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 33JD57L6RW.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 171714-84-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

33JD57L6RW

CAS Registry Number

171714-84-4

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

DARUSENTAN

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C22H22N2O6

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

FEJVSJIALLTFRP-LJQANCHMSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C75991

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

177236

Unique identification number in the NCBI database of chemical substances.

INN ID

7838

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

[C@@H](C(=O)O)(C(c1ccccc1)(OC)c2ccccc2)Oc3nc(OC)cc(n3)OC

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Darusentan. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.